Bank of New York Mellon Corp - MOLECULIN BIOTECH INC ownership

MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D101. A total of 22 filers reported holding MOLECULIN BIOTECH INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of MOLECULIN BIOTECH INC
ValueSharesWeighting
Q4 2019$65,000
-16.7%
70,6780.0%0.00%
Q3 2019$78,000
+90.2%
70,678
+113.8%
0.00%
Q2 2019$41,000
+51.9%
33,0520.0%0.00%
Q1 2019$27,000
-25.0%
33,052
-3.7%
0.00%
Q4 2018$36,00034,3060.00%
Other shareholders
MOLECULIN BIOTECH INC shareholders Q1 2020
NameSharesValueWeighting ↓
Whitegate Investment Counselors, Inc. 97,000$155,0000.03%
Laird Norton Wetherby Wealth Management, LLC 19,792$32,0000.00%
Avondale Wealth Management 2,659$4,0000.00%
TRUIST FINANCIAL CORP 90,000$144,0000.00%
OneDigital Investment Advisors LLC 2,800$4,0000.00%
CIBC WORLD MARKET INC. 89,300$143,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 3,778$6,0000.00%
Global Retirement Partners, LLC 1,000$2,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 126,497$202,0000.00%
View complete list of MOLECULIN BIOTECH INC shareholders